<DOC>
	<DOCNO>NCT01862523</DOCNO>
	<brief_summary>Capsaicin nasal spray use daily practice IR without knowledge exact mechanism involve treatment . Therefore , study aim address issue study functional ( electrophysiologic ) change specific stimulation IR patient healthy control capsaicin/placebo treatment .</brief_summary>
	<brief_title>Mechanisms Capsaicin Treatment Idiopathic Rhinitis Patients Controls</brief_title>
	<detailed_description>As essential step towards improvement treatment IR investigate neural mechanism underlie therapeutic action capsaicin . In particular , plan evaluate effect capsaicin functional property innervation nasal mucosa monitor trigeminal nerve activity use measurement negative mucosa potential ( NMP ) . NMPs , evoke chemical thermal stimulus IR patient healthy control . Considering evidence suggest role sensory C-fibers pathophysiology IR , employ low concentration irritant specifically activate receptor express fiber , i.e. , capsaicin TRPV1 cinnamaldehyde allyl-isothiocyanate ( mustard oil ) TRPA1 . The stimulation perform immediately capsaicin treatment , 4 week , 3 month 6 month . This allow objective assessment functionality C-fiber innervation treatment , phase therapeutic response period recurrence IR symptom . The result NMP measurement contrast therapeutic response evaluation nasal congestion , nasal sensitivity presence neuro-mediators find nasal biopsy . Importantly , independent assessment NMP responses mediate either TRPV1 TRPA1 allow determine specific role nociceptors pathophysiology IR , , turn , may help design specific effective therapy .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>1 . Patients persistent ( &gt; 52w ) rhinological symptom : nasal discharge , sneeze , congestion average least 1 h per day least 5 day period 14 day , negative skin prick test negative RAST , without structural abnormality explain nasal obstruction propose participate trial . 2 . Age &gt; 18 &lt; 60 year 3 . Written inform consent 4 . Willingness adhere visit schedule 5 . Adequate contraceptive precaution female patient childbearing potential 6 . Unresponsiveness nasal steroid spray ( 4 week use ) 1 . Age &lt; 18 &gt; 60 year 2 . Patients AR , demonstrate either positive skin prick test RAST 3 . Asthma 4 . Structural abnormality : nasal polyp , severe septal deviation ( septum reach concha inferior lateral nasal wall . 5 . Systemic steroid treatment le 4 week inclusion study . 6 . Nasal steroid spray le 4 week inclusion , oral leukotriene antagonist longacting antihistamine less 2 week inclusion . 7 . Inability patient stop take medication affect nasal function . 8 . Evidence infectious rhinitis/rhinosinusitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>